![logo](/logos/SEQUA.BR.webp)
Sequana Medical NV
EBR:SEQUA.BR
0.93 (EUR) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Sequana Medical NV |
Symbool | SEQUA.BR |
Munteenheid | EUR |
Prijs | 0.926 |
Beurswaarde | 37,265,481 |
Dividendpercentage | 0% |
52-weken bereik | 0.71 - 4.85 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Ian Crosbie |
Website | https://www.sequanamedical.com |
An error occurred while fetching data.
Over Sequana Medical NV
Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)